Artia Global Partners LP - Q2 2023 holdings

$290 Million is the total value of Artia Global Partners LP's 34 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
MRK  MERCK & CO INC$37,986,388
+8.5%
329,2000.0%13.10%
+1.2%
ABBV  ABBVIE INC$12,236,313
-15.5%
90,8210.0%4.22%
-21.1%
MRNA  MODERNA INC$10,293,359
-20.9%
84,7190.0%3.55%
-26.2%
SGEN  SEAGEN INC$9,849,141
-4.9%
51,1750.0%3.40%
-11.3%
NBIX  NEUROCRINE BIOSCIENCES INC$4,243,500
-6.8%
45,0000.0%1.46%
-13.1%
BNTX  BIONTECH SEsponsored ads$4,005,066
-13.4%
37,1080.0%1.38%
-19.1%
ALNY  ALNYLAM PHARMACEUTICALS INC$3,033,532
-5.2%
15,9710.0%1.05%
-11.5%
TMO  THERMO FISHER SCIENTIFIC INC$2,654,664
-9.5%
5,0880.0%0.92%
-15.6%
ITCI  INTRA-CELLULAR THERAPIES INC$2,634,112
+16.9%
41,6000.0%0.91%
+9.1%
CBAY  CYMABAY THERAPEUTICS INC$1,853,583
+25.6%
169,2770.0%0.64%
+17.2%
CRL  CHARLES RIV LABS INTL INC$1,451,776
+4.2%
6,9050.0%0.50%
-2.9%
 TYRA BIOSCIENCES INC$770,659
+6.0%
45,2530.0%0.27%
-1.1%
WAT  WATERS CORP$758,306
-13.9%
2,8450.0%0.26%
-19.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVO-NORDISK A S4Q3 202325.8%
MERCK & CO INC4Q3 202314.1%
ARGENX SE4Q3 202312.3%
LILLY ELI & CO4Q3 202314.5%
ABBVIE INC4Q3 20235.6%
ASTRAZENECA PLC4Q3 20235.4%
SEAGEN INC4Q3 20234.5%
BIOMARIN PHARMACEUTICAL INC4Q3 20234.3%
NEUROCRINE BIOSCIENCES INC4Q3 20232.1%
VERTEX PHARMACEUTICALS INC4Q3 20232.6%

View Artia Global Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14

View Artia Global Partners LP's complete filings history.

Export Artia Global Partners LP's holdings